Option delistings effective December 23rd include Pieris Pharmaceuticals (PVLA), Nanostring Technologies, Inc. (NSTGQ), NaaS Technology (NAAS), ROUNDHILL DAILY INVERSE MAGNIFICENT SEVEN ETF (MAGQ), Merrimack Pharmaceuticals Inc (MACK), Cue Health Inc (HLTHQ), Galera Therapeutics Inc (GRTX), DermTech Inc (DMTKQ), Cidara Therapeutics (CDTX), Nuburu, Inc. (BURU), Atara Biotherapeutics (ATRA), and RCM Technologies (RCMT).
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PVLA: